木瓜直播

Crystal Phend

Crystal Phend

Authors >

Crystal Phend

Crystal Phend is a contributing editor with 木瓜直播, where she's been covering medical news of all stripes since 2006.

Connect:

email image

Latest from Crystal Phend

A close up of a Black male physician with a weary skeptical look on his face

'No Physician Is Racist'? Twitter Calls Foul on JAMA Podcast

Structural racism podcast episode seen as contributing to the problem

A man with the flu wrapped in a blanket waves at his doctor during a telemedicine call

What Telehealth Should Mean for Licensure

Is it time for states to step back?

A view of a darkened dialysis machine and bed through a broken piece of ice

Dialysis Crisis in Texas: 'Catastrophic'

Half of dialysis units across the state still suffering winter storm havoc

FDA APPROVED Sacubitril/valsartan (Entresto) over a photo of a man clutching his chest which is highlighted in red

First Drug Approved for Some HFpEF

FDA doesn't set hard limits on ejection fraction in expanded indication

An ultrasound image showing stenosis of the carotid artery

USPSTF: Still a Hard Pass on Carotid Artery Stenosis Screening

Science hasn't improved, task force says

Two bottles of Colchicine tablets over an illustrated background of COVID-19 viruses

Colchicine for Early COVID-19? Trial May Support Oral Therapy at Home

But some find science-by-press-release troubling

A young Black female doctor holds a stethoscope up

Recruitment Strategy Increases Cardiology Fellow Diversity

Intervention made women and minorities the majority, with no change in standards

A man on a couch yawns

Lungs Clear but Still Not Well Post-COVID

Months after diagnosis, fatigue is common but lung fibrosis is not

sacubitril/valsartan (ENTRESTO) over a computer rendering of a heart above FDA ADCOMM

FDA Panel Backs Entresto, Spironolactone for Broader HF Use

But committee stops short of advocating categorical approval for HFpEF

Sacubitril/Valsartan (Entresto) over a computer rendering of the cardiovascular system above FDA ADCOMM.

FDA Review Gives Rosy Outlook for What Could Be First HFpEF Drugs

Advisory committee weigh unusual moves for Entresto and spironolactone

鈥�

39

鈥�